Literature DB >> 23242284

Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies.

Elizabeta B Mukaetova-Ladinska1, Alina Andras, Joan Milne, Zeinab Abdel-All, Iwo Borr, Evelyn Jaros, Robert H Perry, William G Honer, Andrea Cleghorn, Jeanette Doherty, Gary McIntosh, Elaine K Perry, Raj N Kalaria, Ian G McKeith.   

Abstract

Functional neuroimaging studies have consistently reported abnormalities in the visual cortex in patients with dementia with Lewy bodies (DLB), but their neuropathologic substrates are poorly understood. We analyzed synaptic proteins and choline acetyltransferase (ChAT) in the primary (BA17) and association (BAs18/19) visual cortex in DLB and similar aged control and Alzheimer disease (AD) subjects. We found lower levels of synaptophysin, syntaxin, SNAP-25, and γ-synuclein in DLB subjects versus both aged control (68%-78% and 27%-72% for BA17 and BAs18/19, respectively) and AD cases (54%-67% and 10%-56% for BA17 and BAs18/19, respectively). The loss in ChAT activity in DLB cases was also greater in BA17 (72% and 87% vs AD and control values, respectively) than in BAs18/19 (52% and 65% vs AD and control groups, respectively). The observed synaptic and ChAT changes in the visual cortices were not associated with tau or β-amyloid pathology in the occipital or the frontal, temporal, and parietal neocortex. However, the neocortical densities of LBs, particular those in BA17 and BAs18/19, correlated with lower synaptic and ChAT levels in these brain areas. These findings draw attention to molecular changes within the primary visual cortex in DLB and correlate with the neuroimaging findings within the occipital lobe in patients with this disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23242284     DOI: 10.1097/NEN.0b013e31827c5710

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  21 in total

1.  Expression of synaptophysin protein in different dopaminergic cell lines.

Authors:  Xiang Bai; Randy Strong
Journal:  J Biochem Pharmacol Res       Date:  2014-12

Review 2.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

3.  Lewy Body Pathology and Chronic Traumatic Encephalopathy Associated With Contact Sports.

Authors:  Jason W Adams; Victor E Alvarez; Jesse Mez; Bertrand R Huber; Yorghos Tripodis; Weiming Xia; Gaoyuan Meng; Caroline A Kubilus; Kerry Cormier; Patrick T Kiernan; Daniel H Daneshvar; Alicia S Chua; Sarah Svirsky; Raymond Nicks; Bobak Abdolmohammadi; Laney Evers; Todd M Solomon; Jonathan D Cherry; Nurgul Aytan; Ian Mahar; Sherral Devine; Sanford Auerbach; Michael L Alosco; Christopher J Nowinski; Neil W Kowall; Lee E Goldstein; Brigid Dwyer; Douglas I Katz; Robert C Cantu; Robert A Stern; Rhoda Au; Ann C McKee; Thor D Stein
Journal:  J Neuropathol Exp Neurol       Date:  2018-09-01       Impact factor: 3.685

4.  Gene expression profiling of brain samples from patients with Lewy body dementia.

Authors:  Maciej Pietrzak; Audrey Papp; Amanda Curtis; Samuel K Handelman; Maria Kataki; Douglas W Scharre; Grzegorz Rempala; Wolfgang Sadee
Journal:  Biochem Biophys Res Commun       Date:  2016-09-22       Impact factor: 3.575

5.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

6.  Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.

Authors:  Martí Colom-Cadena; Jordi Pegueroles; Abigail G Herrmann; Christopher M Henstridge; Laia Muñoz; Marta Querol-Vilaseca; Carla San Martín-Paniello; Joan Luque-Cabecerans; Jordi Clarimon; Olivia Belbin; Raúl Núñez-Llaves; Rafael Blesa; Colin Smith; Chris-Anne McKenzie; Matthew P Frosch; Allyson Roe; Juan Fortea; Jordi Andilla; Pablo Loza-Alvarez; Ellen Gelpi; Bradley T Hyman; Tara L Spires-Jones; Alberto Lleó
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

7.  Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.

Authors:  Erika Bereczki; Rui M Branca; Paul T Francis; Joana B Pereira; Jean-Ha Baek; Tibor Hortobágyi; Bengt Winblad; Clive Ballard; Janne Lehtiö; Dag Aarsland
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

8.  Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations.

Authors:  Ahmad A Khundakar; Peter S Hanson; Daniel Erskine; Nichola Z Lax; Joseph Roscamp; Evangelia Karyka; Eliona Tsefou; Preeti Singh; Simon J Cockell; Andrew Gribben; Lynne Ramsay; Peter G Blain; Urs P Mosimann; Deborah J Lett; Matthias Elstner; Douglass M Turnbull; Charles C Xiang; Michael J Brownstein; John T O'Brien; John-Paul Taylor; Johannes Attems; Alan J Thomas; Ian G McKeith; Christopher M Morris
Journal:  Acta Neuropathol Commun       Date:  2016-06-30       Impact factor: 7.801

9.  Differential involvement of the gamma-synuclein in cognitive abilities on the model of knockout mice.

Authors:  Viktor S Kokhan; Gennadiy I Van'kin; Sergey O Bachurin; Inna Yu Shamakina
Journal:  BMC Neurosci       Date:  2013-05-14       Impact factor: 3.288

10.  Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study.

Authors:  Stefano Delli Pizzi; Raffaella Franciotti; Armando Tartaro; Massimo Caulo; Astrid Thomas; Marco Onofrj; Laura Bonanni
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.